Studies of Receptor Mediated Signal Transduction Processes in Mammalian Cancer Bi

哺乳动物癌症中受体介导的信号转导过程的研究

基本信息

  • 批准号:
    8329723
  • 负责人:
  • 金额:
    $ 12.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-07 至 2014-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): I describe a systems approach to develop and implement novel methods to explore model receptor-mediated signaling in extrinsic apoptosis in mammalian cells based on experimental data. My focus will be on the signaling events from ligand binding at the cellular surface to mitochondrial outer membrane permeabilization and eventual effector caspase activation. The discoveries from this work will also have an impact in prototypical cue-signal-response pathways in molecular cancer cell biology and related fields. I will examine the validity of different competing mechanisms for mitochondrial outer membrane permeabilization using theoretical approaches and complement this with experimental data collected in our laboratory. The calibration of such a model to experimental data will be central aspect of my work. I expect the development of novel theories about apoptosis which will suggest new research directions. A second stage of the proposed work will expand the models to examine the effect of drugs on transformed and non-transformed cells of different types, also based on experimental data. Concurrent with the biological work, I will develop tools that will allow for flexible treatment of complex network models thus facilitating the biological studies. Attention to model tracking, model sharing, and its connection with experiments will be given special attention through the use of semantic- Wiki based software developed in our laboratory for dissemination and outreach of the project. Toward the independent part of the award I will merge my newly acquired cancer molecular cell biology knowledge with my theoretical physical chemistry training to develop tools which accurately describe cellular environments and implement methods to reduce the number of parameters that are difficult to obtain in current modeling efforts. I expect my project to have a profound impact on the study of signaling pathways in apoptosis, the understanding of drugs and their interactions with proteins related to apoptosis, and the development of tools rooted in the needs of cell molecular cancer biology.
描述(由申请人提供):我描述了一种系统方法,用于开发和实施新方法,以基于实验数据探索哺乳动物细胞中外源性凋亡中受体介导的信号传导模型。我的重点将是从细胞表面的配体结合到线粒体外膜透化和最终效应器半胱天冬酶激活的信号事件。这项工作的发现也将对分子癌细胞生物学和相关领域的原型线索-信号-反应途径产生影响。我将研究不同的竞争机制的有效性,线粒体外膜透化使用理论方法和补充,在我们的实验室收集的实验数据。这样一个模型的实验数据的校准将是我的工作的中心方面。我期待着新的理论的发展,凋亡,这将建议新的研究方向。拟议工作的第二阶段将扩展模型,以同样基于实验数据来检查药物对不同类型的转化和非转化细胞的影响。在生物学工作的同时,我将开发工具,允许灵活处理复杂的网络模型,从而促进生物学研究。注意模型跟踪,模型共享,以及它与实验的连接将通过使用语义维基为基础的软件在我们的实验室开发的项目的传播和推广给予特别关注。对于该奖项的独立部分,我将把我新获得的癌症分子细胞生物学知识与我的理论物理化学培训相结合,以开发准确描述细胞环境的工具,并实施方法来减少当前建模工作中难以获得的参数数量。我希望我的项目对细胞凋亡信号通路的研究,药物及其与细胞凋亡相关蛋白质相互作用的理解,以及植根于细胞分子癌症生物学需求的工具的开发产生深远的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Carlos Federico Lopez其他文献

Carlos Federico Lopez的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Carlos Federico Lopez', 18)}}的其他基金

Phenotype Transitions in Small Cell Lung Cancer
小细胞肺癌的表型转变
  • 批准号:
    10411428
  • 财政年份:
    2017
  • 资助金额:
    $ 12.18万
  • 项目类别:
Phenotype Transitions in Small Cell Lung Cancer
小细胞肺癌的表型转变
  • 批准号:
    10176419
  • 财政年份:
    2017
  • 资助金额:
    $ 12.18万
  • 项目类别:
Studies of Receptor Mediated Signal Transduction Processes in Mammalian Cancer Bi
哺乳动物癌症中受体介导的信号转导过程的研究
  • 批准号:
    8535661
  • 财政年份:
    2011
  • 资助金额:
    $ 12.18万
  • 项目类别:
Studies of Receptor Mediated Signal Transduction Processes in Mammalian Cancer Bi
哺乳动物癌症中受体介导的信号转导过程的研究
  • 批准号:
    8111595
  • 财政年份:
    2011
  • 资助金额:
    $ 12.18万
  • 项目类别:

相似海外基金

Mechanisms that underlie the life/death decisions in a cell that activated apoptotic caspases
细胞中激活凋亡半胱天冬酶的生/死决策的机制
  • 批准号:
    10607815
  • 财政年份:
    2023
  • 资助金额:
    $ 12.18万
  • 项目类别:
Nuclear and chromatin aberrations during non-apoptotic cell death in C. elegans and mammals
线虫和哺乳动物非凋亡细胞死亡过程中的核和染色质畸变
  • 批准号:
    10723868
  • 财政年份:
    2023
  • 资助金额:
    $ 12.18万
  • 项目类别:
Non-apoptotic functions of caspase-3 in neural development
Caspase-3在神经发育中的非凋亡功能
  • 批准号:
    10862033
  • 财政年份:
    2023
  • 资助金额:
    $ 12.18万
  • 项目类别:
Apoptotic Donor Leukocytes to Promote Kidney Transplant Tolerance
凋亡供体白细胞促进肾移植耐受
  • 批准号:
    10622209
  • 财政年份:
    2023
  • 资助金额:
    $ 12.18万
  • 项目类别:
Design of apoptotic cell mimetic anti-inflammatory polymers for the treatment of cytokine storm
用于治疗细胞因子风暴的模拟凋亡细胞抗炎聚合物的设计
  • 批准号:
    22H03963
  • 财政年份:
    2022
  • 资助金额:
    $ 12.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identifying the mechanisms behind non-apoptotic functions of mitochondrial matrix-localized MCL-1
确定线粒体基质定位的 MCL-1 非凋亡功能背后的机制
  • 批准号:
    10537709
  • 财政年份:
    2022
  • 资助金额:
    $ 12.18万
  • 项目类别:
Activation of non-apoptotic cell death by the DNA damage response
DNA 损伤反应激活非凋亡细胞死亡
  • 批准号:
    10388929
  • 财政年份:
    2022
  • 资助金额:
    $ 12.18万
  • 项目类别:
Environmental Carcinogens Induce Minority MOMP to Initiate Carcinogenesis in Lung Cancer and Mesothelioma whileMaintaining Apoptotic Resistance via Mcl-1
环境致癌物诱导少数 MOMP 引发肺癌和间皮瘤的癌变,同时通过 Mcl-1 维持细胞凋亡抵抗
  • 批准号:
    10356565
  • 财政年份:
    2022
  • 资助金额:
    $ 12.18万
  • 项目类别:
Targeting apoptotic cells to enhance radiotherapy
靶向凋亡细胞以增强放射治疗
  • 批准号:
    10708827
  • 财政年份:
    2022
  • 资助金额:
    $ 12.18万
  • 项目类别:
Targeting apoptotic cells to enhance radiotherapy
靶向凋亡细胞以增强放射治疗
  • 批准号:
    10538071
  • 财政年份:
    2022
  • 资助金额:
    $ 12.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了